Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Gynecology

Free Subscription 18.03.2019 5 Acta Obstet Gynecol Scand 2 Am J Obstet Gynecol 1 Am J Surg Pathol 1 Ann Oncol 4 BMC Cancer 4 BMJ 1 Br J Cancer 1 Cancer Res 8 Eur J Obstet Gynecol Reprod Biol 17 Fertil Steril 1 Gynecol Endocrinol 21 Gynecol Oncol 2 Hum Reprod 1 Int J Cancer 1 Int J Gynaecol Obstet 1 Int J Oncol 5 Int J Radiat Oncol Biol Phys 1 J Clin Endocrinol Metab 3 J Urol 1 JAMA 1 Lancet 2 Lancet Infect Dis 2 Lancet Oncol 13 Obstet Gynecol 2 Oncogene 1 PLoS Genet 3 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Obstet Gynecol Scand

1. RAVLO M, Lieng M, Bukholm IRK, Haase Moen M, et al
   Approved claims for compensation from gynecological patients in Norway - what characterizes the cases? A 14-year nationwide study.
   Acta Obstet Gynecol Scand. 2019 Mar 12. doi: 10.1111/aogs.13605.
   PubMed     Text format     Abstract available
   
   
2. JENSEN MPS, Damkjaer M, Clausen FB, Ali HA, et al
   Targeted Rhesus immunoglobulin for RhD negative women undergoing an induced abortion: a clinical pilot study.
   Acta Obstet Gynecol Scand. 2019 Mar 12. doi: 10.1111/aogs.13606.
   PubMed     Text format     Abstract available
   
   
3. WALKER K, Strevens H, Thornton J
   Nordic influence on British obstetrics.
   Acta Obstet Gynecol Scand. 2019;98:411-412.
   PubMed     Text format    
   
   
4. BERGENDAHL S, Lindberg P, Brismar Wendel S
   Authors' reply: Experience and education matter, for residents as well as for obstetricians and gynecologists.
   Acta Obstet Gynecol Scand. 2019 Mar 13. doi: 10.1111/aogs.13607.
   PubMed     Text format     Abstract available
   
   
5. HAMMER A, Kahlert J, Gravitt PE, Rositch AF, et al
   Hysterectomy-corrected cervical cancer mortality rates in Denmark during 2002-2015: a registry-based cohort study.
   Acta Obstet Gynecol Scand. 2019 Mar 13. doi: 10.1111/aogs.13608.
   PubMed     Text format     Abstract available
   
   

   
   Am J Obstet Gynecol

6. USUDA H, Watanabe S, Saito M, Sato S, et al
   Successful use of an artificial placenta to support extremely preterm ovine fetuses at the border of viability.
   Am J Obstet Gynecol. 2019 Mar 7. pii: S0002-9378(19)30472.
   PubMed     Text format     Abstract available
   
   
7. DESAI VB, Wright JD, Gross CP, Lin H, et al
   Prevalence, Characteristics, and Risk Factors of Occult Uterine Cancer in Presumed Benign Hysterectomy.
   Am J Obstet Gynecol. 2019 Mar 7. pii: S0002-9378(19)30430.
   PubMed     Text format     Abstract available
   
   

   
   Am J Surg Pathol

8. SARI A, Pollett A, Eiriksson LR, Lumsden-Johanson B, et al
   Interobserver Agreement for Mismatch Repair Protein Immunohistochemistry in Endometrial and Nonserous, Nonmucinous Ovarian Carcinomas.
   Am J Surg Pathol. 2019 Mar 8. doi: 10.1097/PAS.0000000000001220.
   PubMed     Text format     Abstract available
   
   

   
   Ann Oncol

9. JOLY F, Ahmed-Lecheheb D, Kalbacher E, Heutte N, et al
   Long-term fatigue and quality of life among epithelial ovarian cancer survivors: A GINECO case/control VIVROVAIRE I Study.
   Ann Oncol. 2019 Mar 9. pii: 5372686. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

10. LI C, Zhang Q, Zhang S, Dong R, et al
    Squamous cell carcinoma transformation in mature cystic teratoma of the ovary: a systematic review.
    BMC Cancer. 2019;19:217.
    PubMed     Text format     Abstract available
    
    
11. YE S, Liu S, Xiang L, Wu X, et al
    (18)F-FDG PET/CT-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications.
    BMC Cancer. 2019;19:226.
    PubMed     Text format     Abstract available
    
    
12. GAO C, Yao H, Liu H, Feng Y, et al
    TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer.
    BMC Cancer. 2019;19:237.
    PubMed     Text format     Abstract available
    
    
13. MURAKAMI N, Kobayashi K, Shima S, Tsuchida K, et al
    A hybrid technique of intracavitary and interstitial brachytherapy for locally advanced cervical cancer: initial outcomes of a single-institute experience.
    BMC Cancer. 2019;19:221.
    PubMed     Text format     Abstract available
    
    

    
    BMJ

14. THIAGAMOORTHY G
    Dyspareunia: consider urogenital prolapse.
    BMJ. 2018;362:k3979.
    PubMed     Text format    
    
    
15. KEEDWELL R, Byrne D
    Two abnormalities on diagnostic laparoscopy.
    BMJ. 2018;362:k3655.
    PubMed     Text format    
    
    
16. JORGENSEN L, Doshi P, Gotzsche P, Jefferson T, et al
    Challenges of independent assessment of potential harms of HPV vaccines.
    BMJ. 2018;362:k3694.
    PubMed     Text format    
    
    
17. TANNE JH
    AMA and Planned Parenthood sue to halt new US restrictions on abortion.
    BMJ. 2019;364:l1102.
    PubMed     Text format    
    
    

    
    Br J Cancer

18. GORANOVA T, Ennis D, Piskorz AM, Macintyre G, et al
    Correction: Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.
    Br J Cancer. 2019 Mar 13. pii: 10.1038/s41416-019-0433.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

19. NATARAJAN S, Foreman KM, Soriano MI, Rossen NS, et al
    Collagen remodeling in the hypoxic tumor-mesothelial niche promotes ovarian cancer metastasis.
    Cancer Res. 2019 Mar 12. pii: 0008-5472.CAN-18-2616.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

20. SCHMITZ T, Sentilhes L, Lorthe E, Gallot D, et al
    Preterm premature rupture of the membranes: Guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF).
    Eur J Obstet Gynecol Reprod Biol. 2019;236:1-6.
    PubMed     Text format     Abstract available
    
    
21. JARDINE JE, Knight HE, Carroll FE, Gurol-Urganci I, et al
    Risk of obstetric anal sphincter injury in women having a vaginal birth after a previous caesarean section: A population-based cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2019;236:7-13.
    PubMed     Text format     Abstract available
    
    
22. MEKINIAN A, Houfflin-Debarge V, Kolanska K, Cohen J, et al
    Antagonists of TNFalpha for recurrent miscarriages: 2 Illustrative cases.
    Eur J Obstet Gynecol Reprod Biol. 2019 Mar 6. pii: S0301-2115(19)30112.
    PubMed     Text format     Abstract available
    
    
23. BARBIER M, Pivano A, Tourette C, Poizac S, et al
    Evaluation of a follow-up customized strategy for women treated with methotrexate for an ectopic pregnancy: An observational study.
    Eur J Obstet Gynecol Reprod Biol. 2019;236:32-35.
    PubMed     Text format     Abstract available
    
    
24. KAPOOR S, Sivanesan K, Veerasingham M
    Bakri balloon - A cautionary tale.
    Eur J Obstet Gynecol Reprod Biol. 2018;221:203-204.
    PubMed     Text format    
    
    
25. JAIMAN S, Gundabattula SR, Dasari S, Pochiraju M, et al
    Atypical xanthogranulomatous inflammation of the female genital tract.
    Eur J Obstet Gynecol Reprod Biol. 2018;222:186-187.
    PubMed     Text format    
    
    
26. MILANI R, Cola A, Palmieri S, Manodoro S, et al
    Gluteo-vaginal fistula after prolapse mesh surgery.
    Eur J Obstet Gynecol Reprod Biol. 2018;225:266-267.
    PubMed     Text format    
    
    
27. TAMER EREL C
    Case report: Vulvodynia treated with Erbium:YAG laser.
    Eur J Obstet Gynecol Reprod Biol. 2018;231:280-281.
    PubMed     Text format    
    
    

    
    Fertil Steril

28. LEWIS TD, Malik M, Britten J, Parikh T, et al
    Ulipristal acetate decreases active TGF-beta3 and its canonical signaling in uterine leiomyoma via two novel mechanisms.
    Fertil Steril. 2019 Mar 11. pii: S0015-0282(19)30011.
    PubMed     Text format     Abstract available
    
    
29. MACDONALD JA, Takai Y, Ishihara O, Seki H, et al
    Extracellular matrix signaling activates differentiation of adult ovary-derived oogonial stem cells in a species-specific manner.
    Fertil Steril. 2019 Mar 11. pii: S0015-0282(18)32301.
    PubMed     Text format     Abstract available
    
    
30. AZZIZ R
    Defining what is normal: the key to the diagnosis of polycystic ovary syndrome (and any other disorder for that matter...).
    Fertil Steril. 2019 Mar 11. pii: S0015-0282(19)30019.
    PubMed     Text format    
    
    
31. MORENO I, Simon C
    An endometrial pathology in the inflammation cloud that can be accessed with a microbial app.
    Fertil Steril. 2019 Mar 11. pii: S0015-0282(19)30003.
    PubMed     Text format    
    
    
32. AHMAD AK, Quinn M, Kao CN, Greenwood E, et al
    Improved diagnostic performance for the diagnosis of polycystic ovary syndrome using age-stratified criteria.
    Fertil Steril. 2019 Mar 11. pii: S0015-0282(18)32245.
    PubMed     Text format     Abstract available
    
    
33. ZAKHARI A, Sanders AP, Murji A
    Uterine artery occlusion at myomectomy.
    Fertil Steril. 2019 Mar 11. pii: S0015-0282(19)30057.
    PubMed     Text format     Abstract available
    
    
34. BEDAIWY MA
    Uterine artery occlusion at myomectomy? Toward a better definition of the indications.
    Fertil Steril. 2019 Mar 7. pii: S0015-0282(19)30062.
    PubMed     Text format    
    
    
35. BARNHART KT
    Introduction: Fertility as a window to health.
    Fertil Steril. 2018;110:781-782.
    PubMed     Text format     Abstract available
    
    
36. SENAPATI S
    Infertility: a marker of future health risk in women?
    Fertil Steril. 2018;110:783-789.
    PubMed     Text format     Abstract available
    
    
37. ADASHI EY, Schlaff WD
    Against all odds: the first state infertility mandate (Maryland).
    Fertil Steril. 2018;110:824-825.
    PubMed     Text format    
    
    
38. CANIS M, Gremeau AS, Bourdel N
    Elusive adenomyosis: a plea for an international classification system to allow artificial intelligence approaches to reset our clinical management.
    Fertil Steril. 2018;110:1039-1040.
    PubMed     Text format    
    
    
39. TELLUM T, Nygaard S, Skovholt EK, Qvigstad E, et al
    Development of a clinical prediction model for diagnosing adenomyosis.
    Fertil Steril. 2018;110:957-964.
    PubMed     Text format     Abstract available
    
    
40. BLANK C, Duijf IT, Slappendel E, Mischi M, et al
    External validation of a prediction model to select the best day-three embryo for transfer in in vitro fertilization or intracytoplasmatic sperm injection procedures.
    Fertil Steril. 2018;110:917-924.
    PubMed     Text format     Abstract available
    
    
41. BORTOLETTO P, Prabhu M, Garry EM, Huybrechts KF, et al
    Opioid dispensing patterns after oocyte retrieval.
    Fertil Steril. 2018;110:905-909.
    PubMed     Text format     Abstract available
    
    
42. 
    Current recommendations for vaccines for female infertility patients: a committee opinion.
    Fertil Steril. 2018;110:838-841.
    PubMed     Text format     Abstract available
    
    
43. 
    Diagnostic evaluation of sexual dysfunction in the male partner in the setting of infertility: a committee opinion.
    Fertil Steril. 2018;110:833-837.
    PubMed     Text format     Abstract available
    
    
44. ARENDT LH, Lindhard MS, Kjersgaard C, Henriksen TB, et al
    Parental subfertility and hypospadias and cryptorchidism in boys: results from two Danish birth cohorts.
    Fertil Steril. 2018;110:826-832.
    PubMed     Text format     Abstract available
    
    

    
    Gynecol Endocrinol

45. LUO X, Cheng R, Zhang J, Ma Y, et al
    Evaluation of body composition in POF and its association with bone mineral density and sex steroid levels.
    Gynecol Endocrinol. 2018;34:1027-1030.
    PubMed     Text format     Abstract available
    
    

    
    Gynecol Oncol

46. FOOTE JR, Secord AA, Liang MI, Ehrisman JA, et al
    Targeted composite value-based endpoints in platinum-sensitive recurrent ovarian cancer.
    Gynecol Oncol. 2019;152:445-451.
    PubMed     Text format     Abstract available
    
    
47. SUIDAN RS, He W, Sun CC, Zhao H, et al
    National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer.
    Gynecol Oncol. 2019;152:439-444.
    PubMed     Text format     Abstract available
    
    
48. LAVIE O, Chetrit A, Novikov I, Sadetzki S, et al
    Fifteen-year survival of invasive epithelial ovarian cancer in women with BRCA1/2 mutations - the National Israeli Study of Ovarian Cancer.
    Gynecol Oncol. 2019 Mar 11. pii: S0090-8258(19)30132.
    PubMed     Text format     Abstract available
    
    
49. PRESCOTT LS, Taylor JS, Enbaya A, Marten CA, et al
    Choosing Wisely: Decreasing the incidence of perioperative blood transfusions in gynecologic oncology.
    Gynecol Oncol. 2019 Mar 11. pii: S0090-8258(19)30156.
    PubMed     Text format     Abstract available
    
    
50. RUENGKHACHORN I, Phithakwatchara N, Viriyapak B, Sangkarat S, et al
    Comparison of oncologic outcomes of unanticipated cervical carcinoma in women undergoing inadvertent simple hysterectomy and those undergoing surgical treatment after preoperative diagnosis.
    Gynecol Oncol. 2019 Mar 11. pii: S0090-8258(19)30135.
    PubMed     Text format     Abstract available
    
    
51. MORA PAR, Sun SY, Velarde GC, Filho JR, et al
    Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?
    Gynecol Oncol. 2019 Mar 8. pii: S0090-8258(19)30153.
    PubMed     Text format     Abstract available
    
    
52. MURAKAMI R, Matsumura N, Michimae H, Tanabe H, et al
    The mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin than to conventional taxane and carboplatin chemotherapy in high grade serous ovarian carcinoma: A survey of Japanese Gynecologic Oncology G
    Gynecol Oncol. 2019 Mar 7. pii: S0090-8258(19)30120.
    PubMed     Text format     Abstract available
    
    
53. FELIP I, Moiola CP, Megino-Luque C, Lopez-Gil C, et al
    Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer.
    Gynecol Oncol. 2019 Mar 7. pii: S0090-8258(19)30150.
    PubMed     Text format     Abstract available
    
    
54. DOO DW, Kirkland CT, Griswold LH, McGwin G, et al
    Comparative outcomes between robotic and abdominal radical hysterectomy for IB1 cervical cancer: Results from a single high volume institution.
    Gynecol Oncol. 2019 Mar 6. pii: S0090-8258(19)30149.
    PubMed     Text format     Abstract available
    
    
55. TAYLOR JS, Zhang N, Rajan SS, Chavez-MacGregor M, et al
    How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients.
    Gynecol Oncol. 2019;152:452-458.
    PubMed     Text format     Abstract available
    
    
56. KWON JS, Tinker AV, Hanley GE, Pansegrau G, et al
    BRCA mutation testing for first-degree relatives of women with high-grade serous ovarian cancer.
    Gynecol Oncol. 2019;152:459-464.
    PubMed     Text format     Abstract available
    
    
57. VELENTZIS LS, Smith MA, Simms KT, Lew JB, et al
    Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia.
    Gynecol Oncol. 2019;152:465-471.
    PubMed     Text format     Abstract available
    
    
58. RATNER E, Bala M, Louie-Gao M, Aydin E, et al
    Increased risk of brain metastases in ovarian cancer patients with BRCA mutations.
    Gynecol Oncol. 2019 Mar 12. pii: S0090-8258(19)30152.
    PubMed     Text format     Abstract available
    
    
59. MOSS HA, Melamed A, Wright JD
    Measuring cause-and-effect relationships without randomized clinical trials: Quasi-experimental methods for gynecologic oncology research.
    Gynecol Oncol. 2019;152:533-539.
    PubMed     Text format     Abstract available
    
    
60. CALO C, Elliott JO, Clements A, Reid G, et al
    Cervical cancer radiation therapy compliance rates based on location of radiation therapy.
    Gynecol Oncol. 2019;152:528-532.
    PubMed     Text format     Abstract available
    
    
61. ZAKEM SJ, Robin TP, Smith DE, Amini A, et al
    Evolving trends in the management of high-intermediate risk endometrial cancer in the United States.
    Gynecol Oncol. 2019;152:522-527.
    PubMed     Text format     Abstract available
    
    
62. GRESSEL GM, Dioun SM, Richley M, Lounsbury DW, et al
    Utilizing the Patient Reported Outcomes Measurement Information System (PROMIS(R)) to increase referral to ancillary support services for severely symptomatic patients with gynecologic cancer.
    Gynecol Oncol. 2019;152:509-513.
    PubMed     Text format     Abstract available
    
    
63. MEYER LA, Shi Q, Lasala J, Iniesta MD, et al
    Comparison of patient reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery.
    Gynecol Oncol. 2019;152:501-508.
    PubMed     Text format     Abstract available
    
    
64. WANG XS, Shi Q, Williams LA, Cleeland CS, et al
    Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN).
    Gynecol Oncol. 2019;152:492-500.
    PubMed     Text format     Abstract available
    
    
65. KUMAR A, Nesbitt KM, Bakkum-Gamez JN
    Quality improvement in gynecologic oncology: Current successes and future promise.
    Gynecol Oncol. 2019;152:486-491.
    PubMed     Text format     Abstract available
    
    
66. NGUYEN JMV, Sadeghi M, Gien LT, Covens A, et al
    Impact of a preventive bundle to reduce surgical site infections in gynecologic oncology.
    Gynecol Oncol. 2019;152:480-485.
    PubMed     Text format     Abstract available
    
    

    
    Hum Reprod

67. STEWART EA, Diamond MP, Williams ARW, Carr BR, et al
    Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
    Hum Reprod. 2019 Mar 13. pii: 5377830. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
68. FRAGOULI E, McCaffrey C, Ravichandran K, Spath K, et al
    Corrigendum. Clinical implications of mitochondrial DNA quantification on pregnancy outcomes: a blinded prospective non-selection study.
    Hum Reprod. 2019 Mar 13. pii: 5377827. doi: 10.1093.
    PubMed     Text format    
    
    

    
    Int J Cancer

69. HAMERS FF, Assogba FAG, Rogel A
    Implementation and organization of cancer screening in France.
    Int J Cancer. 2018;143:3281.
    PubMed     Text format    
    
    

    
    Int J Gynaecol Obstet

70. KASELITZ EB, James KH, Aborigo RA, Agorinya I, et al
    Understanding the gap in emergency obstetric and neonatal care in Ghana through the PREventing Maternal And Neonatal Deaths (PREMAND) study.
    Int J Gynaecol Obstet. 2019 Mar 15. doi: 10.1002/ijgo.12803.
    PubMed     Text format     Abstract available
    
    

    
    Int J Oncol

71. ZHANG W, Ou X, Wu X
    Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis.
    Int J Oncol. 2019 Mar 7. doi: 10.3892/ijo.2019.4742.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

72. HAUGE A, Gaustad JV, Huang R, Simonsen TG, et al
    DCE-MRI and Quantitative Histology Reveal Enhanced Vessel Maturation but Impaired Perfusion and Increased Hypoxia in Bevacizumab-Treated Cervical Carcinoma.
    Int J Radiat Oncol Biol Phys. 2019 Mar 8. pii: S0360-3016(19)30315.
    PubMed     Text format     Abstract available
    
    
73. MASON SA, White IM, O'Shea T, McNair HA, et al
    Combined ultrasound and cone beam CT improves target segmentation for image guided radiation therapy in uterine cervix cancer.
    Int J Radiat Oncol Biol Phys. 2019 Mar 11. pii: S0360-3016(19)30316.
    PubMed     Text format     Abstract available
    
    
74. KLOPP A
    Radiation Is the Place to Start.
    Int J Radiat Oncol Biol Phys. 2018;100:289.
    PubMed     Text format    
    
    
75. OLAWAIYE AB
    Chemo First, Then Radiation, and Perhaps Surgery.
    Int J Radiat Oncol Biol Phys. 2018;100:290-291.
    PubMed     Text format    
    
    
76. CHINO J
    Chemo-radiation, Then on to Surgery.
    Int J Radiat Oncol Biol Phys. 2018;100:290.
    PubMed     Text format    
    
    

    
    J Clin Endocrinol Metab

77. PODE-SHAKKED N, Blau A, Pode-Shakked B, Tiosano D, et al
    Combined gestational age- and birth weight-adjusted cutoffs for newborn screening of congenital adrenal hyperplasia.
    J Clin Endocrinol Metab. 2019 Mar 13. pii: 5374693. doi: 10.1210/jc.2018-02468.
    PubMed     Text format     Abstract available
    
    

    
    J Urol

78. SEFTEL AD
    Re: The Importance of Male Ejaculation for Female Sexual Satisfaction and Function.
    J Urol. 2019;201:426.
    PubMed     Text format    
    
    
79. NIEDERBERGER C
    Re: High-Intensity Exercise Training for Improving Reproductive Function in Infertile Patients: A Randomized Controlled Trial.
    J Urol. 2018;199:331.
    PubMed     Text format    
    
    
80. CADEDDU JA
    Re: Early Repair of Post-Hysterectomy Vesicovaginal Fistulae through a Laparoscopic Transperitoneal Extravesical Approach. Experience of a Single Center.
    J Urol. 2019 Mar 13:101097JU0000000000000216. doi: 10.1097/JU.0000000000000216.
    PubMed     Text format    
    
    

    
    JAMA

81. BRUSTAD N, Eliasen AU, Stokholm J, Bonnelykke K, et al
    High-Dose Vitamin D Supplementation During Pregnancy and Asthma in Offspring at the Age of 6 Years.
    JAMA. 2019;321:1003-1005.
    PubMed     Text format    
    
    

    
    Lancet

82. ZHAO F, Qiao Y
    Cervical cancer prevention in China: a key to cancer control.
    Lancet. 2019;393:969-970.
    PubMed     Text format    
    
    

    
    Lancet Infect Dis

83. MACFADDEN DR, Lipsitch M, Olesen SW, Grad Y, et al
    Multidrug-resistant Neisseria gonorrhoeae: implications for future treatment strategies.
    Lancet Infect Dis. 2018;18:599.
    PubMed     Text format    
    
    
84. FIFER H, Cole M, Hughes G, Padfield S, et al
    Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational study.
    Lancet Infect Dis. 2018 Mar 6. pii: S1473-3099(18)30122.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Oncol

85. NOUT RA, Powell ME, de Boer SM, Creutzberg CL, et al
    Investigators' response.
    Lancet Oncol. 2018;19:602.
    PubMed     Text format    
    
    
86. GOURD E
    No benefit of lymphadenectomy for advanced ovarian cancer.
    Lancet Oncol. 2019 Mar 7. pii: S1470-2045(19)30140.
    PubMed     Text format    
    
    

    
    Obstet Gynecol

87. WONG S, Naresh A
    Etonogestrel Subdermal Implant-Associated Regression of Endometrial Intraepithelial Neoplasia.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003152.
    PubMed     Text format     Abstract available
    
    
88. LAZORWITZ A, Aquilante CL, Oreschak K, Sheeder J, et al
    Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant Users.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003189.
    PubMed     Text format     Abstract available
    
    
89. AYALA NK, Rouse DJ
    A Nudge Toward Universal Aspirin for Preeclampsia Prevention.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003167.
    PubMed     Text format     Abstract available
    
    
90. WEN T, Wright JD, Goffman D, D'Alton ME, et al
    Hypertensive Postpartum Admissions Among Women Without a History of Hypertension or Preeclampsia.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003099.
    PubMed     Text format     Abstract available
    
    
91. COPE AG, Mara KC, Weaver AL, Casey PM, et al
    Postpartum Contraception Usage Among Somali Women in Olmsted County, Minnesota.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003154.
    PubMed     Text format     Abstract available
    
    
92. JORGENSEN EM, Modest AM, Hur HC, Hacker MR, et al
    Hysterectomy Practice Patterns in the Postmorcellation Era.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003181.
    PubMed     Text format     Abstract available
    
    
93. WINKEL AF
    The Backstory Behind Burnout in Obstetrics and Gynecology.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003195.
    PubMed     Text format    
    
    
94. VINEKAR K, Rush SK, Chiang S, Schiff MA, et al
    Educating Obstetrics and Gynecology Residents on Transgender Patients: A Survey of Program Directors.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003173.
    PubMed     Text format     Abstract available
    
    
95. MACKEY A, Ng JI, Core J, Nguyen L, et al
    Three-Dimensional-Printed Uterine Model for Surgical Planning of a Cesarean Delivery Complicated by Multiple Myomas.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003107.
    PubMed     Text format     Abstract available
    
    
96. WHITE K, Baum SE, Hopkins K, Potter JE, et al
    Change in Second-Trimester Abortion After Implementation of a Restrictive State Law.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003183.
    PubMed     Text format     Abstract available
    
    
97. DUFFY CR, D'Alton ME, Han YW, Goldenberg RL, et al
    Incorporating Precesarean Vaginal Preparation Into Standard of Care for Obstetrics.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003153.
    PubMed     Text format     Abstract available
    
    
98. DOTTINO JA, Moss HA, Lu KH, Secord AA, et al
    U.S. Food and Drug Administration-Approved Poly (ADP-Ribose) Polymerase Inhibitor Maintenance Therapy for Recurrent Ovarian Cancer: A Cost-Effectiveness Analysis.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003171.
    PubMed     Text format     Abstract available
    
    
99. ENGLISH EM, Bell S, Kamdar NS, Swenson CW, et al
    Importance of Estimated Blood Loss in Resource Utilization and Complications of Hysterectomy for Benign Indications.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003182.
    PubMed     Text format     Abstract available
    
    

    
    Oncogene

100. LIU Y, Zhou H, Zhu R, Ding F, et al
     SPSB3 targets SNAIL for degradation in GSK-3beta phosphorylation-dependent manner and regulates metastasis.
     Oncogene. 2018;37:768-776.
     PubMed     Text format     Abstract available
     
     
101. MITAMURA T, Pradeep S, McGuire M, Wu SY, et al
     Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP).
     Oncogene. 2018;37:722-731.
     PubMed     Text format     Abstract available
     
     

     
     PLoS Genet

102. GOBE C, Elzaiat M, Meunier N, Andre M, et al
     Dual role of DMXL2 in olfactory information transmission and the first wave of spermatogenesis.
     PLoS Genet. 2019;15:e1007909.
     PubMed     Text format     Abstract available
     
     

     
     PLoS One

103. YAMAMOTO N, Hirata T, Izumi G, Nakazawa A, et al
     A survey of public attitudes towards third-party reproduction in Japan in 2014.
     PLoS One. 2018;13:e0198499.
     PubMed     Text format     Abstract available
     
     
104. DHAYAT NA, Marti N, Kollmann Z, Troendle A, et al
     Urinary steroid profiling in women hints at a diagnostic signature of the polycystic ovary syndrome: A pilot study considering neglected steroid metabolites.
     PLoS One. 2018;13:e0203903.
     PubMed     Text format     Abstract available
     
     
105. ZHENG G, Yu H, Kanerva A, Forsti A, et al
     Familial risks of ovarian cancer by age at diagnosis, proband type and histology.
     PLoS One. 2018;13:e0205000.
     PubMed     Text format     Abstract available
     
     

     
     Proc Natl Acad Sci U S A

106. LI C, Bonazzoli E, Bellone S, Choi J, et al
     Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors.
     Proc Natl Acad Sci U S A. 2018 Dec 24. pii: 1814027116.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: